Literature DB >> 8286103

erbB-3, a third member of the erbB/epidermal growth factor receptor gene family: its expression in head and neck cancer cell lines.

W J Issing1, W J Heppt, E R Kastenbauer.   

Abstract

Proto-oncogenes encoding growth factor receptors constitute several distinct families with close overall structural homology. The highest degree of homology can be observed in their catalytic domains, which are essential for intrinsic tyrosine kinase activity. Growth factor receptors in several of these families play critical roles in the regulation of normal cell growth and development. Some of these molecules have been implicated in the neoplastic process as well. A related DNA fragment distinct from epidermal growth factor receptor and erbB-2 genes was detected by reduced stringency hybridization of v-erbB to normal genomic human DNA. The expression of erbB-3 was studied by southern and northern blot technique in a subset of nine head and neck tumor cell lines, as well as in three immortalized cultures established from normal human salivary glands. No gene amplification of erb-B-3 was noted in any of the head and neck cell lines. The 6.2 kb transcript of erbB-3 was elevated significantly in an epidermoid carcinoma of the larynx (A388) and an esophageal carcinoma (HA 114).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286103     DOI: 10.1007/BF00180383

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  35 in total

1.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

Authors:  K D Somers; S L Cartwright; G L Schechter
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

2.  Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study.

Authors:  C Moore
Journal:  JAMA       Date:  1971-10-25       Impact factor: 56.272

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Oncogenes of RNA tumor viruses as determinants of cancer.

Authors:  R J Huebner; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

6.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

7.  Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.

Authors:  M H Kraus; N C Popescu; S C Amsbaugh; C R King
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

8.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.

Authors:  J Ishitoya; M Toriyama; N Oguchi; K Kitamura; M Ohshima; K Asano; T Yamamoto
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

9.  Increased EGF receptors on human squamous carcinoma cell lines.

Authors:  G P Cowley; J A Smith; B A Gusterson
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

10.  Oncogene amplification in squamous cell carcinoma of the oral cavity.

Authors:  D Saranath; R G Panchal; R Nair; A R Mehta; V Sanghavi; J Sumegi; G Klein; M G Deo
Journal:  Jpn J Cancer Res       Date:  1989-05
View more
  5 in total

1.  c-erbB3 protein expression in ovarian cancer.

Authors:  T Rajkumar; G W Stamp; C M Hughes; W J Gullick
Journal:  Clin Mol Pathol       Date:  1996-08

2.  Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

Authors:  P O-charoenrat; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.

Authors:  Chi-Son Chang; Jung In Shim; Sun-Ju Byeon; Eun Jin Lee; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Chel Hun Choi
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

4.  Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.

Authors:  Eleftherios Vairaktaris; Lambros Goutzanis; Stavros Vassiliou; Sofia Spyridonidou; Emeka Nkenke; Georgios Papageorgiou; Pashalis Strantzias; Andreas Lazaris; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-18       Impact factor: 4.553

5.  Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma.

Authors:  Giovanni Almadori; Antonella Coli; Eugenio De Corso; Dario Antonio Mele; Stefano Settimi; Giovanni Di Cintio; Francesca Brigato; Domenico Scannone; Thomas E Carey; Gaetano Paludetti; Libero Lauriola; Franco Oreste Ranelletti
Journal:  J Transl Med       Date:  2021-09-27       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.